AstraZeneca

• AstraZeneca says it’s withdrawing COVID vaccine amid low demand

  AstraZeneca says a surplus of other available COVID-19 vaccines and declining demand are the reasons behind why it's withdrawing Vaxzevria.

  Health

  May 8, 2024
  
• AstraZeneca to buy Ontario cancer treatment developer Fusion Pharmaceuticals

  Fusion, based in Hamilton, is focused on developing radioconjugates which are used to deliver radiation directly to cancer cells.

  Canada

  Mar 19, 2024
  
• Advertisement
• AstraZeneca says it will prioritize U.S. market for RSV drug

  AstraZeneca AZN.L on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus.

  Health

  Nov 10, 2023
• Advertisement
• Approval of AstraZeneca’s Evusheld COVID treatment in Canada is ‘good news,’ experts say

  AstraZeneca Canada said in a press release that its Evusheld has received a Notice of Compliance from Health Canada to treat COVID-19 for those aged 12 or older.

  Health

  Oct 19, 2022
• Canada to throw away more than half of expired AstraZeneca vaccine doses

  Canada also has yet to explain how it plans to manage millions of doses of both Novavax and Medicago vaccines that the country bought.

  Health

  Jul 5, 2022
• J&J’s COVID-19 vaccine restricted by FDA due to rare but serious blood clot risk

  U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.

  Health

  May 5, 2022
• COVID-19: Booster shot uptake rises in Sask. as province adds 829 new cases, 14 deaths

  There were 829 new COVID-19 cases confirmed last week in Saskatchewan with 231 cases found in the Saskatoon zone and 141 in the Regina zone.

  Health

  Apr 28, 2022
• Health Canada OKs AstraZeneca’s Evusheld drug for COVID-19 prevention

  AstraZeneca's Evusheld contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.

  Canada

  Apr 14, 2022
• Advertisement
• AstraZeneca forecasts 2022 growth even as COVID revenue wanes

  While sales of COVID-19 products are expected to decline by a low-to-mid 20s percentage this year, Astrazeneca forecast overall revenues to rise by a high teens percentage.

  Consumer

  Feb 10, 2022
• Advertisement
• AstraZeneca says it is working on an Omicron vaccine with Oxford

  "Together with Oxford University, we have taken preliminary steps in producing an Omicron variant vaccine, in case it is needed," a spokesperson for the company said.

  World

  Dec 21, 2021